Citation Impact
Citing Papers
Identification and Characterization of a Ligand-independent Oligomerization Domain in the Extracellular Region of the CD95 Death Receptor
1999
Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses
2004
Hepatocellular carcinoma
2003 Standout
A novel, rapid and sensitive heterotypic cell adhesion assay for CD2–CD58 interaction, and its application for testing inhibitory peptides
2004
Acute kidney injury
2012 Standout
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis.
1998
RNA interference targeting Fas protects mice from fulminant hepatitis
2003
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
Delayed graft function in kidney transplantation
2004 Standout
Organ crosstalk: the role of the kidney
2009
Liver fibrosis
2005 Standout
Hepatitis C Virus Infection
2001 Standout
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo
1999 Standout
Signal Transduction by the JNK Group of MAP Kinases
2000 Standout
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
1999 Standout
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Hepatitis C Virus–Associated Fulminant Hepatic Failure
1996
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels
1998
The Immune Reactivity Role of HCV-Induced Liver Infiltrating Lymphocytes in Hepatocellular Damage
1997
Nonalcoholic Fatty Liver Disease
2002 Standout
Apoptosis by Death Factor
1997 Standout
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
2000
Cytotoxic T cells and viral hepatitis.
1997
Putranjivain A from Euphorbia jolkini inhibits proliferation of human breast adenocarcinoma MCF-7 cells via blocking cell cycle progression and inducing apoptosis
2005
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Reactive Oxygen Intermediates Are Involved in the Induction of CD95 Ligand mRNA Expression by Cytostatic Drugs in Hepatoma Cells
1997
Apoptosis: The nexus of liver injury and fibrosis
2004
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Genetics of hepatocellular carcinoma
2000
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
2010 StandoutNature
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
1997
Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species
2004
FasGene Mutations in the Canale–Smith Syndrome, an Inherited Lymphoproliferative Disorder Associated with Autoimmunity
1996
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas
2002
The C. elegans Protein EGL-1 Is Required for Programmed Cell Death and Interacts with the Bcl-2–like Protein CED-9
1998 StandoutNobel
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Systemic amyloidosis
2015 Standout
Domino Liver Transplantation: Risks and Benefits
2008
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Helicobacter pyloriInfection
2002 Standout
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Revealing the world of RNA interference
2004 StandoutNatureNobel
Osteoporosis after solid organ and bone marrow transplantation
2003
Assessment of renal graft function by perioperative monitoring of cortical microcirculation in kidney transplantation.1
2003
Amoebiasis
2003 Standout
Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?
1996
Errors of homeostasis and deregulated apoptosis
1997
Phosphorylation of H2AX at Short Telomeres in T Cells and Fibroblasts
2004 StandoutNobel
Hepatic Resection Versus Transplantation for Hepatocellular Carcinoma
1991
The TNF and TNF Receptor Superfamilies
2001 Standout
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis
2003
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication
1993
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation
1996
Anemia of Chronic Disease
2005 Standout
DNA Damaging Agents Induce Expression of Fas Ligand and Subsequent Apoptosis in T Lymphocytes via the Activation of NF-κB and AP-1
1998
Replication of hepatitis C virus
2007 StandoutNobel
Perforin-Independent CD8 + T-Cell–Mediated Cytotoxicity of Alveolar Epithelial Cells Is Preferentially Mediated by Tumor Necrosis Factor- α
1999
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice
2002 StandoutNobel
Proteasome regulation of activation-induced T cell death
1997 StandoutNobel
A Simple Detection Method for Low-Affinity Membrane Protein Interactions by Baculoviral Display
2008 StandoutNobel
Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity
1998
Fracture after cardiac transplantation: a prospective longitudinal study.
1996
Death Receptors: Signaling and Modulation
1998 StandoutScience
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
1998
Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning
2003
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
2000 StandoutScienceNobel
Involvement of TRAIL and its receptors in viral hepatitis
2002
Chemical and Pharmacological Research of the Plants in Genus Euphorbia
2008 Standout
Interleukin 1β-converting Enzyme Related Proteases/Caspases Are Involved in TRAIL-induced Apoptosis of Myeloma and Leukemia Cells
1997
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
2003 Standout
Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis
2003
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
1999
Bile Acid Regulation of C/EBPβ, CREB, and c-Jun Function, via the Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Pathways, Modulates the Apoptotic Response of Hepatocytes
2003
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias
1995
Identification of Amino Acid Residues Important for Ligand Binding to Fas
1997
Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein
1997
Entamoeba histolyticaInduces Host Cell Death in Amebic Liver Abscess by a Non-Fas-Dependent, Non-Tumor Necrosis Factor Alpha-Dependent Pathway of Apoptosis
1998
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Works of G. Otto being referenced
Early assessment of reperfusion injury by intraoperative quantification of hepatic microcirculation in patients
1997
Effects of Mixed ETA and ETB-Receptor Antagonist (Ro-47-0203) on Hepatic Microcirculation After Warm Ischemia
1997
Role of hepatitis C virus infection in German patients with fulminant and subacute hepatic failure
1992
Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liver
1997
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study
1994
Is transplantation really superior to resection in the treatment of small hepatocellular carcinoma?
1997
Bone disease after liver transplantation.
1992
Evaluation of soluble tumor necrosis factor receptors after orthotopic liver transplantation.
1992
Prolonged allograft survival by the inhibition of costimulatory CD2 signals but not by modulation of CD48 (CD2 ligand) in the rat
1996
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
1995
Liver transplantation and de novo hepatitis B Infection
1994
Prolonged allograft survival by the inhibition of costimulatory CD2 signals but not by modulation of CD48 (CD2 ligand) in the rat
1996
p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
1994
Recurrence of hepatitis C virus infection after orthotopic liver transplantation.
1992
Primary hepatic malignancies: resection or liver transplantation?
1990